跳至主要内容
临床试验/JPRN-UMIN000003987
JPRN-UMIN000003987已完成未知

Study for evaluating efficacy and safety of TACE with miriplatin in the treatment of patients with hepatocellular carcinoma - MELT study

Tokai University School of Medicine, Department of Internal Medicine, Division of Gastroenterology0 个研究点目标入组 40 人开始时间: 2010年8月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who have hypersensitiby to iodine or contrast media. 2. Patients who have severe thyroid or heart diseases. 3. Patients who have uncontrolled malignancies other than HCC. 4. Patients who are pregnant or lactating.

研究者

发起方
Tokai University School of Medicine, Department of Internal Medicine, Division of Gastroenterology

相似试验